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Abstract
Background: Childhood overweight and obesity is a serious public health issue with an increase being observed in
preschool-aged children. Treating childhood obesity is difficult and few countries use standardized treatments.
Therefore, there is a need to find effective approaches that are feasible for both health care providers and families.
Thus, the overall aim of this study is to assess the acceptance and effectiveness of a parent support program (the
More and Less, ML) for the management of overweight and obesity followed by a mobile health (mHealth)
program (the MINISTOP application) in a socially diverse population of families.
Methods/design: A two-arm, parallel design randomized controlled trial in 300 2-to 6-year-old children with
overweight and obesity from Romania, Spain and Sweden (n = 100 from each). Following baseline assessments
children are randomized into the intervention or control group in a 1:1 ratio. The intervention, the ML program,
consists of 10-weekly group sessions which focus on evidence-based parenting practices, followed by the
previously validated MINISTOP application for 6-months to support healthy eating and physical activity behaviors.
The primary outcome is change in body mass index (BMI) z-score after 9-months and secondary outcomes include:
waist circumference, eating behavior (Child Eating Behavior Questionnaire), parenting behavior (Comprehensive
Feeding Practices Questionnaire), physical activity (ActiGraph wGT3x-BT), dietary patterns (based on metabolic
markers from urine and 24 h dietary recalls), epigenetic and gut hormones (fasting blood samples), and the overall
acceptance of the overweight and obesity management in young children (semi-structured interviews).
Outcomes are measured at baseline and after: 10-weeks (only BMI z-score, waist circumference), 9-months
(all outcomes), 15- and 21-months (all outcomes except physical activity, dietary patterns, epigenetics and gut
hormones) post-baseline.
Discussion: This study will evaluate a parent support program for weight management in young children in
three European countries. To boost the effect of the ML program the families will be supported by an app for
6-months. If the program is found to be effective, it has the potential to be implemented into routine care to
reduce overweight and obesity in young children and the app could prove to be a viable option for sustained
effects of the care provided.
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Background
According to the World Health Organization childhood
obesity is one of the gravest public health challenges of
today’s society [1], with approximately 108 million 2- to
19-year-old children being classified as having obesity
[2]. More specifically, in children less than 5 years, there
has been a swift increase in childhood overweight and
obesity and if these trends continue it is predicted that
70 million children will be overweight or obese by 2025
[3]. These statistics are concerning as Geserick et al. [4]
found that 90% of 3 year olds with obesity still had over-
weight or obesity in adolescence. Furthermore, for those
adolescents with overweight or obesity, the majority of
weight gain happened between two and 6 years of age
[4]. Thus, this demonstrates the need for evidence-based
treatment programs in the pre-school years in order to
attempt to rectify the increased prevalence of childhood
overweight and obesity.
According to Colquitt et al. [5] for children under 6
years of age multicomponent interventions (i.e., diet,
physical activity, and behavioral interventions) seem to
be effective at treating overweight and obesity. However,
the authors did state that evidence is limited [5]. To
date, the majority of the treatment interventions for
overweight and obesity use face-to-face delivery methods
[6]. A recent meta-analysis by Ling et al. [6] found small
effect sizes on treatment interventions for preschool-
aged children for body mass index (BMI) (− 0.28 kg/m2,
p < 0.001) using various in person delivery methods. Fur-
thermore, the More and Less (ML) study found that at
the 12-month follow-up, a 10-week group treatment
program focusing on parenting practices had a greater
reduction in BMI z-scores than standard treatment in
health care (− 0.30 vs. -0.07, p < 0.05). An even greater
reduction was observed in the intervention group who
received booster sessions (a 30-min phone call every 4
to 6 weeks over a 9-month period) [7]. These results are
promising; however, sustained contacts with families after
treatment programs are burdensome on both health care
providers and participants, which makes it difficult to
scale-up. Therefore, different types of boosters need to be
used in order to reduce the burden on both health care
and participants.
The universal use of smartphones makes the use of
mobile health (mHealth) an option for boosting the ef-
fects of treatment programs. mHealth is increasingly be-
ing used for promoting healthy habits and as treatment
of many types of health conditions and diseases. In
adults, two meta-analyses have found that mHealth in-
terventions focusing on weight loss significantly de-
creased participants’ weight in the intervention groups
compared to the control groups [8, 9]. In children and
adolescents few studies have utilized mHealth in the pre-
vention or treatment of obesity [10–14] and hardly any
have been conducted in the preschool-age group [15, 16].
The Mobile-based Intervention Intended to Stop Obesity
in Preschoolers (MINISTOP) trial was a mHealth obesity
prevention intervention that was developed and led by
Marie Löf and her team to improve 4-year-old children’s
body composition, dietary, physical activity, and sedentary
behaviors [17, 18]. The MINISTOP intervention had a
significant effect on a composite score composed of body
composition, diet, and physical activity variables, with this
effect being more evident among children with a higher
fat mass index [18]. There are numerous advantages of
mHealth over conventional intervention approaches such
as: the programs can be delivered any time and place; are
interactive; can be tailored to different groups (e.g., trans-
lated into multiple languages); and reduces burden on
health care professionals and participants. These advan-
tages further motivates the use of mHealth in families with
young children with overweight and obesity.
The mechanisms that drive weight gain such as epigenet-
ics and gut hormones are still unclear [19, 20]. Epigenetics
has received attention during the recent years for the puta-
tive involvement in transmitting obesity risk to offspring
and in the heritable regulation of gene expression without
altering their coding sequence [21]. The most relevant
epigenetic mechanisms involved in gene activity control
are histone modifications, non-coding RNAs (ncRNA) and
DNA methylation [20]. Further, obesity has been associated
with the epigenetic modulation of several genes. For
example, a relationship has been reported between in-
creased BMI and adiposity as well as higher DNA
methylation levels at the hypoxia-inducible transcription
factor 3A (HIF3A) gene [22]. Moreover, an increased
methylation in the gene RXRA measured at birth has been
associated with greater adiposity in later childhood [23].
Two other investigations identified a strong correlation
between obesity and serum levels of micro RNA (miR)-
122 and miR-519d [24] and found DNA methylation to
be related to insulin resistance [25]. However, these
findings need to be confirmed and further explored in
young children.
Another field of interest for obesity is the gastrointes-
tinal tract (GIT) [26]. The GIT plays an important role
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in acute appetite regulation through a number of mecha-
nisms: (1) the release of hormones that play a role in
appetite regulation such as anorectic hormones (Peptide
YY, PYY, and glucagon-like peptide, GLP-1) and orexo-
genic gut hormones (e.g., ghrelin), (2) the enteric ner-
vous system and signals through the vagus to the brain
to influence appetite and (3) secondary to stimulating
signals from other organs such as liver adipose. Previous
research in adults has demonstrated that the infusion of
the GIT anorectic hormones PYY and GLP-1 at physio-
logical doses has profound effects to suppress appetite
[26]. Also weight loss appears to lead to a suppression of
PYY and GLP-1 suggesting a role in the feelings of hun-
ger during weight reduction. However, evidence of the
role of GIT hormones in overweight and obesity among
young children is sparse.
A major challenge in the management of obesity in
both adults and children is understanding what people
eat. Most dietary assessment methodologies use methods
of self-reported food intake which is a subject to large
misreporting error [27, 28]. It is therefore impossible to
understand what children eat. Garcia et al. has devel-
oped a new metabolomic methodology of dietary assess-
ment using urine, which is not subject to the same
misreporting errors [29]. This method has been validated
in adults. Our aim is to do this is children.
To the best of our knowledge there is no study to date
that has the ambition to assess a broad array of key bio-
logical and social determinants of obesity in young children.
This study protocol outlines the design of a multi-country
study that incorporates both a parent support program
and mHealth in an overweight and obesity interven-
tion in 2- to 6-year-old children with overweight and
obesity.
Aim
The overall aim of this study is to assess the feasibility,
acceptance and effectiveness of an overweight and
obesity intervention in a socially diverse population of
families. The specific aims are:
1. To determine the effectiveness on child weight
status (BMI z-score) of a 10-week parent support
program delivered in groups focusing on evidence-
based parenting practices (the ML program)
followed by a mHealth component for 6-months
(the MINISTOP application, app) for overweight
and obesity in preschool-aged children.
2. To assess change in secondary outcomes, which
are: waist circumference, child eating behavior,
parental feeding practices, and physical activity.
3. To assess epigenetic mechanisms and physio
pathological processes underlying childhood obesity
including the role of gut hormones.
4. To assess and validate child food intake with
metabolic markers in urine metabolomics.
5. To evaluate the feasibility of recruitment
(facilitators and barriers), attrition and acceptability
of the ML program, the standard treatment and the
overall acceptance of overweight and obesity
management according to patients and care
providers.
Hypotheses
Our central hypothesis is that the intervention (the ML
program followed by the MINISTOP app for boosting)
will be more effective in decreasing children’s BMI z-score
(primary outcome), improving eating and feeding behav-
iors, and physical activity (secondary outcomes) compared
to standard care. Another study hypothesis is that the
intervention will produce changes in urinary metabolites,
which will serve as biomarkers of the nutritional outcomes
or as targets for application. We also hypothesize that the
parent program and the mHealth intervention will be well
accepted by families and caregivers.
Methods
Study design
ML Europe is a two-arm parallel design randomized
controlled trial (RCT) comparing overweight and obesity
treatments in 2-to 6-year-old children in three countries
(Romania, Spain, and Sweden). Following baseline assess-
ments, participants will be randomized into the interven-
tion and control group in a 1:1 ratio. The intervention
group receives a 10-week parent support program (the ML
program) which focuses on evidence-based parenting prac-
tices [7, 30] followed by a previously validated 6-month
mHealth program (the MINISTOP app, PI: M Löf) to sup-
port healthy lifestyle changes [17, 18]. The control group
receives standard treatment as offered in the country of
participation. The different interventions are described in
greater detail below. Assessments will be conducted at
10 weeks, 9 months, 15 months, and 21 months post-
baseline (see Fig. 1 for study outline). This study proto-
col follows the SPIRIT 2013 statement [31, 32].
Sample size and power calculation
Based on power calculations, 75 children are needed in
each group (adjusted for drop-out) to detect a difference
of 0.3 BMI z-score with 85% power at the 9-month
follow-up between the intervention and control group.
These calculations are based on a previous study in this
age group [33]. Thus, each site aims to recruit 100 par-
ticipants to ensure adequate power.
Participants, eligibility, and recruitment
In total, we aim to include 300 families (n = 100 in
Romania, Spain, and Sweden, respectively). To be
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included in this study: children must be between 2 and
6 years old and have overweight or obesity as classified
by international cut-offs [34]; have no other underlying
medical condition(s); the child has not started any treat-
ment for overweight or obesity; and at least one parent
has to have the ability to communicate in Romanian,
Spanish, or Swedish depending on the country of partici-
pation. Parents who do not own a smartphone compat-
ible with the MINISTOP app will be excluded from this
study (i.e., version 10.0 or higher for iOS or version 5.0
or higher for Android).
Recruitment will follow a standardized protocol for all
countries. In Romania, family physicians and pediatricians
will be involved to hand out information regarding the
study to families with 2- to 6-year-olds with overweight or
obesity. Parents who want to learn more about the study
are provided with a phone number, email address, web
page and Facebook page with information of how to
contact the research group. Participants will also be re-
cruited, as self-referrals, using an official page for the
study on Facebook to be shared with specialized groups.
In Spain, families with children who attend weight and
height assessments at their pediatricians at primary care
health centers and hospitals will be asked to participate
in the study. If the parents are interested in participat-
ing, the pediatrician will schedule a visit within a max-
imum of 7 days to provide them with more detailed
information regarding the study and for them to sign the
informed consent.
Finally, in Sweden, the recruitment methods have been
previously described in detail [7, 30]. Briefly, recruitment is
done primarily at primary child health care centers, where
all parents of children from birth to 5 years of age are
offered free, yearly check-ups. If overweight or obesity is
detected the nurse provides a verbal and a short one-page
explanation of the study. If the parent(s) are interested in
Fig. 1 Flow-chart of the More and Less Europe trial design
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participating the nurse sends a referral to the research
group that will send out more detailed information regard-
ing the study together with a consent letter. After 1 week,
a member from the research team will contact the families
to answer any questions that they have. Recruitment is also
conducted at secondary health care (i.e., out-patient
pediatric clinics). Additionally, self-recruitment is being
done through newspaper ads as well as by placing posters
on primary health care bulletin boards.
For all countries, after fully informing the families, if
they still want to participate they send back the signed
consent letter, which is subsequently signed by a mem-
ber of the research team and a copy is sent back to the
family. A time for baseline assessments is then scheduled
with the research group.
Randomization and blinding
After the consent form has been signed, the participants
are randomly allocated to either the intervention group
(parent support program and mHealth booster) or the
control group (standard care as per country) at a 1:1 ra-
tio via a random allocation sequence list (in blocks of
three). The sequence list was generated using free soft-
ware environment for statistical computing and graphics
R (version 3.5.1) [35]. The random allocation sequence
is managed by a person who has no relationship with re-
cruitment or treatment and opaque envelopes are used
to ensure concealment. Those assessing the outcomes
are blinded to the treatment allocation; however, owing
to the nature of the intervention participants are not
blind to their allocation.
Intervention
The More and Less program
The ML program is based on the Keeping Foster and
Kin Parents Supported and Trained (KEEP) parenting
program, which has been tested in multiple settings
[36–39]. KEEP is based on Bandura’s Social Learning
Theory [40] and Patterson’s Social Interaction Learning
Theory [41, 42]. The key concept of the programs is to
support parents in evidence-based parenting practices, es-
pecially regarding positive reinforcement and limit setting,
in order to improve parent and child communication. In
ML, the improved communication lays the foundation for
parents to support a healthy lifestyle for the child.
The ML program is comprised of 10 weekly sessions
(1.5 h/week) and is culturally adapted for Romanian,
Spanish, and Swedish families with preschool aged children
with overweight or obesity. Table 1 displays the content of
the ML program [7, 30]. Beyond the evidence-based par-
enting practices, the program includes content regarding
healthy food habits, physical activity habits, as well as tech-
niques to help parents regulate emotional control. Each
session begins with a theoretical introduction to a
parenting skill, the focus of the session is then discussed
and practice is done through role play and homework as-
signments. To facilitate the implementation of the ML pro-
gram it follows a manual where the sessions are described
with precise instructions to the group leaders (2 per group)
. The parents receive a manual which summarizes what
has been discussed during each session. For parents who
are unable to attend sessions, the parental manual is sent
home to the family and the family is contacted by phone
for a brief review of the session. To facilitate session at-
tendance the time and location for the groups are planned
to suit the parents. Child care is also provided during
the sessions.
The ML group leaders received an initial 4 day train-
ing in child overweight and obesity management and in
the ML program content. The training was provided by
the ML program developers PN and AE. During the
training the sessions of the program were thoroughly
discussed and the group leaders were trained in how to
deliver the program by acting as group leaders while the
Table 1 Session content of the More and Less program and
themes included in the MINISTOP app
More and Less Parenting Program
Session Content
1 Welcome and overview
2 Food and play: When more? When less?
3 Parents as teachers: cooperation and energy balance
4 Parents as teachers: to teach children new behaviors
5 Rewards and incentives
6 Pre-teaching
7 Parents as teachers: limit setting strategies
8 Power struggles: to avoid and to handle them
9 More support – Less stress
10 Summary: parenting, food and play – to prepare for the future
MINISTOP app
Theme Content
1 Healthy foods in general
2 Breakfast
3 Healthy small meals
4 Physical activity and sedentary behavior
5 Candy and sweets
6 Fruits and vegetables
7 Drinks
8 Eating between meals
9 Fast food
10 Sleep
11 Foods outside the home
12 Foods at special occasions
Ek et al. BMC Public Health          (2019) 19:945 Page 5 of 13
other participants acted as parents. The training of
group leaders will continue by external supervision after
each weekly session for the first group in all countries.
The group leaders will be asked to watch the filmed ses-
sions and reflect on how they delivered the program. In
Sweden and in Spain, groups will be held in health care
facilities and in Romania in university facilities.
The MINISTOP app
The MINISTOP app was developed and evaluated in a
population based study with preschool aged children
(PI: Marie Löf ) and has been previously described in
detail [17, 18]. Briefly, MINISTOP comprises of an ex-
tensive program of information and push notifications
built using current guidelines for a healthy diet and
physical activity in pre-school aged children [43]. Over
the 6-month period 12 themes will be covered (Table 1)
. A new theme is introduced bi-weekly, with parents
being alerted by a push notification when this happens.
Every theme is split into three parts (general information;
advice; and strategies to change unwanted behavior).
Through the app, parents have the ability to register their
child’s consumption of sugar sweetened beverages, candy,
fruits and vegetables, and physical activity and sedentary
behavior. Parents then receive feedback on the registered
parameters at the end of every week. Reminder messages
are sent out to parents if they have not been in the app
after a couple of days [17].
Two days before the tenth and final session of the ML
program, parents receive an email with a username and
password for the MINISTOP app as well as a text mes-
sage with a link to download the app. At the final ses-
sion, the ML program leaders will ensure that all parents
were able to download the app and sign in. Thereafter,
they will explain how the app works to the parents and
answer any questions that they may have.
Control
The weight management offered to the control group fol-
lows the standard care procedure for each country of par-
ticipation. In Romania and Spain, the control group
receives an evaluation of a one-day food frequency ques-
tionnaire as well as a 30-min consultation with a doctor
that is a specialist in childhood nutrition, where healthy life-
style recommendations are made. The parents also receive
a hand-out which provides general recommendations for
healthy food and physical activity in 2 to 6 year olds. Fur-
thermore, in Romania the children are re-evaluated after 3
months during a 15-min consultation. In Sweden, the con-
trol group receives standard care according to the Action
plan for overweight and obesity for Stockholm County [44].
Children with overweight and children with obesity youn-
ger than 4 years receive support from their child health care
nurse. Children older than for 4 years with obesity are
followed in an outpatient pediatric clinic with yearly visits
to a pediatrician and follow-up visits to a pediatric nurse,
approximately 5 visits (30min in duration) per year [7].
The treatment centers around supporting the family in cre-
ating healthy diet and physical activity habits for the child.
Children may also be referred to dieticians, psychologists or
physiotherapists.
Measures
Outcome measures are collected at baseline, 10 weeks, 9
months, 15 months, and 21 months post baseline. Table 2
presents when outcome measures are assessed and the
instruments used to assess child and parental behaviors
are displayed in Table 3.
Primary outcome
BMI z-score is the primary outcome measure which is
the most commonly used indicator of weight change in
pediatric obesity studies [47]. The children’s weight and
height will be measured to the nearest 0.1 kg and 0.1 cm,
respectively. A fixed stadiometer is used to assess height
and weight will be measured with the children wearing
only underwear. BMI is derived as weight (kg) divided
by height (m) squared. BMI z-scores are then calculated
using age and gender specific reference values [34].
Secondary outcomes
Waist circumference Waist circumference is measured
at the mid-point between the lower rib and iliac crest to
the nearest 0.1 cm using a non-elastic tape measurer.
Weight, height and waist circumference are measured
three times and mean values are then calculated. All chil-
dren are measured in a standardized manner by trained
health care professionals using calibrated instruments.
Eating behavior The children’s eating behavior is assessed
using the Child Eating Behavior Questionnaire (CEBQ)
[45]. It includes 35 items on eating styles comprising eight
factors related to the risk of obesity. Parents rate each
behavior on a five-point Likert scale (`never´, `rarely´,
`sometimes´, `mostly´, and `always´ for items 1 to 13 and
`disagree´, `slightly disagree´, `neutral´, `slightly agree´,
and `agree´ for items 14 to 49). Mean scores for each sub-
scale are calculated. This questionnaire has been found to
have high internal reliability and good validity [45, 48–53].
Parenting behavior The Comprehensive Feeding Prac-
tices Questionnaire (CFPQ) is used to measure parenting
behavior [46]. The CFPQ is a parent-report instrument,
designed to measure feeding practices of parents of chil-
dren aged 2–8 years. It contains 49 items comprising 12
factors, where parents rate each behavior on a five-point
Likert scale (`never´, `rarely´, `sometimes´, `mostly´, and
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`always´). The CFPQ has previously been validated in
Brazilian preschoolers [54].
Physical activity and sedentary behavior The Acti-
Graph wGT3x-BT accelerometer (ActiGraph Corp,
Pensacola, USA, www.actiGraphcorp.com) is used to
assess physical activity and sedentary behavior over seven
consecutive 24 h periods. The ActiGraph will be attached
the child’s non-dominant wrist and be worn at all times,
except for water-based activities (e.g., showering/bathing
or swimming). The recorded movements will be used to
estimate time in various activity levels based on appropri-
ate cut-points.
Metabolites of food intake First void urinary samples
will be collected from the children and will be used
to assess metabolites of food intake. Two urine sam-
ples from the child will be collected by the parents
at home six and 3 days before the visit to the re-
search group. The third urine sample is collected on
the morning of the visit to the research group. The
urine metabolite analysis will be carried out as previ-
ously described [29]. In brief, urine samples will be
measured by proton nuclear magnetic resonance
(1H-NMR) spectroscopy. Global urinary 1H-NMR
profiles will be used to predict the quality of the diet
using the World Health Organization guidelines as a
Table 2 Socio-demographic characteristics and outcome measures collected at different time points









Weight and height (BMI z-score) Measured by health care professionals x x x x x
Waist circumference x x x x x
Date of birth Child background questionnaire x
Country of birth x
Sex x
Health status x x x x
Family structure x x x x
Daycare x x x x
Visits to health care regarding weight x x x x
Screen time x x x x
Breakfast consumption x x x x
Sugar sweetened drinks consumption x x x x
Eating behavior Child Eating Behavior Questionnaire x x x x
Physical activity / sedentary behavior ActiGraph wGT3x-BT accelerometer x x
Food intake Urine samples, 24 h dietary recall x x
Gut hormones Fasting blood samples x x
Epigenetic markers Fasting blood samples x x
Parent
Weight and height (BMI) Parent background questionnaire x x x x
Date of birth x
Country of birth x
Sex x
Education level x
Health status x x x x
Occupation status x x x x
Income x x x x
Social and economic support from
network
x x x x
Perceived level of comfortable life x x x x
Parenting behavior Comprehensive Feeding Practices
Questionnaire
x x x x
Abbreviations: BMI body mass index
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reference. Individual urinary metabolites associated
with the intake of foods will be used to assess the diet-
ary profile of the child. The Dietary Metabotype Score
that embodies concentrations of urinary metabolites re-
lated to food components and adherence to diet will be
developed and validated against one 24-h dietary recall
with a parent. The 24-h recall will cover the day before
the visit to the research group. For children attending
preschool a food diary for teachers to fill out will be
collected to cover the food intake not provided by the
parent.
Epigenetic markers and gut hormones Fasting blood
samples are collected to assess reversibility of metabolic
markers through epigenetic markers and the role of gut
hormones.
Epigenetic markers
The epigenetic analysis is carried out in white blood cells,
which require DNA extraction, bisulphite transformation,
and analysis with Polymerase chain reactions (PCRs) or
other technologies involving hypothesis driven methyla-
tion (CpGs). The unit of measurement/criteria is changes
in percentage CpGs. The methodology has been explained
in detail elsewhere [55, 56]. Methylation levels will be
analyzed following standardized epigenetic methods after
bisulphite conversion as described previously [55, 56] in
hypothesis- driven specific CpGs.
Gut hormones
PYY concentrations will be measured using an in-house
radioimmunoassay (RIA). The assays are highly sensitive
and do not cross-react with other gut hormones. Separ-
ation of the antibody-antigen complexes from the free
Table 3 Measures used in the study
Instrument, reference Domains No. items Description
Child Eating Behavior Questionnaire (CEBQ), 35
Wardle et al. 2001 [45] Food approach
Food responsiveness 5 The child’s general appetite
Enjoyment of food 4 The child’s interest in food
Emotional overeating 4 If the child eats as a response to emotions
Desire to drink 3 The child’s desire to drink
Food avoidance
Satiety responsiveness 5 If the child gets full easily or not
Slowness in eating 4 The child’s speed of eating
Emotional undereating 4 If the child eats less in response
to emotions




Musher-Eizenman & Holub 2007 [46] Monitoring 4 Parents keep track of child’s intake of less healthy foods
Emotional regulation 3 Parents use food to regulate the child’s emotional stress
Food as a reward 3 Parents use food as a reward for child behaviour
Child control 5 Parents allow the child control of his/her eating behaviors
and parent-child feeding interactions
Modeling 4 Parents actively demonstrate healthy eating for the child
Restriction for weight 8 Parents control the child’s food intake with the purpose of
decreasing or maintaining the child’s weight
Restriction for health 4 Parents control the child’s food intake with the purpose
of limiting less healthy foods and sweets
Teaching nutrition 3 Parents use explicit didactic techniques to encourage the
consumption of healthy foods
Encourage balance and variety 4 Parents promote well-balanced food intake, including the
consumption of varied foods and healthy food choices
Pressure to eat 4 Parents pressure the child to consume more food at meals
Healthy environment 4 Parents make healthy foods available in the home
Involvement 3 Parent’s encourage child’s involvement in meal planning
and preparation
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antigen is achieved by secondary antibody. The reported
intra- and inter-assay variation is 5.8 and 9.8%
respectively.
GLP-1 concentrations will be measured using an in-
house RIA. This assay is highly specific and sensitive with
the antibody cross reacting with 100% of all amidated forms
of GLP-1. The assay does not cross react with glycine ex-
tended forms (GLP1–37 and GLP9–37) or any other gut
hormones. The lowest level of GLP-1 that can be detected
by this assay is 7.5 pmol/l. Separation of the antibody-
antigen complexes from the free antigen is achieved by
charcoal adsorption. The reported in-house intra- and
inter-assay variation is 5.4 and 11.5% respectively.
Feasibility, attrition, and acceptability Using semi-
structured interviews, the facilitators and barriers of re-
cruitment as well as attrition to the intervention (first 10
weeks, i.e., the ML parent program) and feasibility and ac-
ceptability of the MINISTOP app and of the standard care
offered are assessed. Both parents and healthcare profes-
sionals are interviewed by trained research staff. During
the interviews a set of questions are asked to all partici-
pants follow-up questions are however based on individ-
ual responses. The questions have been tested in pilot
interviews with both parents and health care professionals.
The interviews are recorded and fully transcribed. Inter-
views will be conducted before and after the intervention.
Sociodemographic data At baseline parents are asked
to fill out a background questionnaire for the child and
themselves. Questions for the parent include: health sta-
tus, sociodemographic factors and social support. For
the child, questions include: country of birth, health sta-
tus, family structure and lifestyle related questions such
as food and screen time behaviors.
Adverse events
Adverse events will be monitored, reported and handled
appropriately. The risks imposed by this research project
are deemed to be low, i.e., the burden of the experiments
for the research subjects is limited. It is important to
note that blood samples collected in the study are op-
tional and not a criteria for participation. However,
blood samples are taken by experienced nurses and a
pain reducing cream is used to reduce any discomfort.
Urinary samples are none invasive and thus cause no
risk to the participants. In addition, the investigators
have extensive experience conducting behavioral weight
control studies, and active efforts will be taken by the re-
search staff to ensure the participating families’ safety.
Other adverse events may include psychosocial burden
that parents may experience when made aware about
their child’s weight status and the sense of guilt that may
arise. To handle that, already in the first session of the
ML program causes and consequences are reviewed in a
non-judgmental way. Also, potential impact on the
child’s self-esteem and the way to talk about body weight
and obesity with children, if necessary, are addressed.
Data management
All collected data will be handled as approved by the ethical
boards to protect confidentiality. Data is de-identified and
entered manually into a database by research staff at the par-
ticipating site where the data originated from. An identical
database is used at each site. To ensure data quality and val-
idity the researchers follow standard operation procedure
protocols when entering data. The entered data will be
double checked by the person entering the data and random
checks will be performed regularly to ensure data validity.
The database will be password protected and access is re-
stricted to researchers with passwords. Original data forms
will be stored in a secure place at each study site.
Statistical analysis
Intention-to-treat analysis using generalized linear mixed
models with repeated measures will be used to examine
the effects of the intervention on primary (aim 1) and
secondary outcomes (aim 2) for the total study popula-
tion (i.e., all three sites). The link function for the pri-
mary outcome (BMI z-score) will be the identity and the
Gaussian family (equivalent to a linear regression). In
secondary outcomes we will use a Gaussian identity and
family link function for waist circumference, physical
activity and sedentary behavior, and a logarithmic link
and Poisson family function (equivalent to a Poisson re-
gression) for child eating behavior and parental feeding
practices. A random effect for country will be used to
account for the clustered study design. In the models,
we will control for relevant covariates such as sex, age,
parental weight status, education level, income and for-
eign background. Random intercept and a random slope
for time will be included in the model to control those
non-observed confounders specific to each child that
could be constant or vary in time, respectively. Further-
more, interactions between variables will be estimated. If
missing values in the outcomes (primary and secondary)
are more than 10%, these will be imputed through a two-
part model (also known as a model for semi continuous
data). In this model, we would simultaneously estimate
the probability of not being missing (first part) and the
outcome (second part), using a mixed generalized linear
model, in which we would include, as explanatory vari-
ables: age, sex, parental weight status, foreign background,
educational level, and the random effects which are
aforementioned.
Statistical tests and analyses of the interaction of
phenotypical outcomes with epigenetics will include
Manhattan plots, volcano plots, principal component
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analysis (PCA)/cluster, heatmaps, partial least square-
discriminant analysis (PLS-DA), correlations and asso-
ciation studies, linear regression models, receiver op-
erating characteristic (ROC) curves and these will be
implemented as appropriate.
The means and medians for the gut hormone values
before and after the intervention will be compared, using
Student’s t test and Mann-Whitney U test, respectively.
The differences will be adjusted in a generalized linear
mixed model, with an identity link and Gaussian family,
including the confounders, both observed and unob-
served, indicated above.
For the validation of child food intake with metabolic
markers in urine, the urinary dietary model will be derived
using previously described methodology [29]. Comparison
between the study groups will be carried out using PCA
and Monte Carlo cross-validated partial least square-
discriminant analysis (MCCV-PLS-DA) methodology. The
relationship between dietary biomarkers and the dietary
metabolite profile will be carried out using a generalized
linear mixed model, with an identity link and Gaussian
family, including, again, the confounders.
The semi-structured interviews with parents and
health care professional will be fully transcribed verba-
tim and analyzed using thematic analysis [57].
For our analyses we will use R [35], STATA version
12.1 (StataCorp 2011, College Station, TX, USA) and
SPSS Statistics (IBM, Armonk, NY, USA).
Ethics approval
This trial was approved by: the Ethics Committee of Sci-
entific Research in University of Medicine and Pharmacy
“Victor Babes”, Timisoara, Romania, October 31st, 2018
(25/31.10.2018), the Balearic Islands Ethics Committee,
Mallorca, Spain, February 13th, 2019 (IB 3814/18 PI),
and the Research Ethics Committee, Stockholm, Sweden,
December 11th, 2018 (2018/2082–31/1). Written in-
formed consent is obtained from all parents/caregivers.
The ethics committees approved the consent procedure.
Trial status
In Sweden and Romania recruitment began in January
2019 and Spain began to recruit in February 2019. Re-
cruitment is expected to last until 2020.
Discussion
The ML Europe trial will assess the impact of parent
support group sessions (the ML program) followed by a
mHealth program (the MINISTOP app) to treat over-
weight and obesity in 2- to 6-year-old children from
three European countries. Globally, there has been very
few overweight and obesity treatment interventions tar-
geted to pre-school aged children [6] and to date no
intervention has coupled face-to-face delivery with
mHealth to boost the effect of the intervention.
In this trial we aim to recruit a representative sample
of the study population in each participating country. In
Sweden this will be done by inviting all primary and sec-
ondary health care centers in Stockholm County to par-
ticipate in recruitment, with a similar process being
done in Spain (all primary health care centers and hospi-
tals in Mallorca were invited to participate). However, the
ability to get a representative sample of the study popula-
tion in Romania might be more difficult as recruitment re-
lies on families contacting the research team themselves
through contacts with physicians and pediatricians and
Facebook announcements. Therefore, certain parts of the
population may be missed, e.g., those not likely to contact
the research team and those who do not use Facebook.
Additionally, there are a few other factors that should
be considered with regards to recruitment, which have
the possibility to influence the representativeness of the
overall sample. Firstly, the participating families need to
be able to understand, speak, and read Romanian, Span-
ish, or Swedish sufficiently well (depending on the coun-
try of participation) in order to participate. Secondly,
families with low socioeconomic status and parents with
a lower educational background have been found to be
less likely to participate in research [58, 59]. The inability
to speak the language the intervention is being conducted
in coupled with the possibility of low participation rates in
families with low socioeconomic status is of concern. This
is due to the fact that children of migrant parents and
those of low socioeconomic status are more likely to have
overweight or obesity [60, 61]. Furthermore, families will
only be included if they own a smartphone compatible
with the MINISTOP app, which could affect recruitment
of low socioeconomic families; however, we believe this
risk to be quite small as smartphones are so commonly
used in most populations. Finally, we foresee that recruit-
ment for this study will be a challenge as was found in the
ML trial [7]. In the ML trial parents decided not to partici-
pate for various reasons, with the most common being
parents’ work schedules or family situation [7]. When
recruiting for ML Europe we used our experiences from
previous clinical RCTs to ensure that recruitment and pa-
tient participation are organized in the most feasible way,
e.g., time, date and place for the parent groups will be ad-
justed to suit as many families as possible. We anticipate
the recruitment to be influenced by target population size
which varies between the countries (330,000 in Timisoara,
860,000 in Mallorca and 2.3 million in Stockholm County)
. Also, we are aware that the prevalence of overweight and
obesity among children differs in each site. While recent
national data are yet to be published, in Romania, a study
including 6-year-old children found the prevalence for
overweight and obesity to be 19% [62]. In Spain, the
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prevalence of overweight and obesity was 21% in 3 to 5-
year-old children [63]. In the Stockholm County, the
prevalence of overweight and obesity among 4-year-old
children is on average 11% ranging from 4% in the more
affluent areas to over 15% in less affluent areas [64]. Thus,
although the prevalence and obesity seems to be lowest in
the Swedish site the larger population may compensate
this challenge. It remains to be elucidated what the largest
barrier in the recruitment process will be: not sufficiently
large targeted population or low prevalence of overweight
and obesity.
The randomized controlled design and multi-site re-
cruitment (i.e., Timisoara, Romania; Mallorca, Spain; and
Stockholm, Sweden) are strengths of this study. Further-
more, the fairly large sample size (n = 300) will allow us to
assess the intervention’s effectiveness in samples within
and across three very different European countries. With
regards to the intervention, both components are based
on behavior change theories (i.e., Bandura’s Social Learn-
ing Theory [40] and Patterson’s Social Interaction Learn-
ing Theory [41, 42] for the ML program and Social
Cognitive Theory [65] for the MINISTOP program). Fur-
thermore, the combination of group sessions followed by
a previously evaluated mHealth app is a further strength,
as it will allow for the reiteration of the material taught
during the group sessions to be explained in different ways
with different examples. This is important as the booster
group in the ML study had a mean change in BMI z-score
from baseline which was significantly larger in com-
parison to standard treatment and the group without
boosters (− 0.54, p < 0.001; − 0.11, p = 0.551; and − 0.04
for the booster, without boosters, and standard treat-
ment groups, respectively) [7]. In today’s society, tele-
phone based booster sessions after an intervention
such as ML is difficult to sustain due to parents’ busy
schedules. Therefore, a mHealth solution such as
MINISTOP to booster the effect of treatment may be
a more feasible approach as it allows parents to work
through the material at their own pace, when they
have time. Finally, this study is limited by the fact
that there is no standard overweight and obesity
treatment across Europe. Therefore, the control group
will receive different treatment depending on the
country of participation, which could influence the re-
sults. However, standard treatment as per country is
the best possible control as it would be considered
unethical to withhold treatment for a condition if a
treatment exists [66].
The use of objective assessments for anthropometrics
and body composition, physical activity and sedentary
behavior, food intake, as well as epigenetic and metabolic
markers is a further strength of this study. Additionally,
the use of qualitative methods, i.e., semi-structured in-
terviews with health care professionals and parents from
all sites will allow us to assess the feasibility of this new
overweight and obesity management intervention in
three European countries.
In conclusion, in the majority of countries, there is no
standard management of overweight and obesity in the
pre-school years. As overweight and obesity in this age may
track into adolescence and adulthood, causing psycho-
logical and physical consequences, families should receive
support as early as possible. Feasible and effective ap-
proaches for families with pre-school aged children are yet
to be developed. If the ML Europe intervention is found to
be effective, it has the potential to be implemented into
routine care for overweight and obesity across Europe.
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